آزمایش ها

Celldx is a tissue-based comprehensive molecular profiling of solid tumours with the aim of personalising therapy options. The ...
With chemo-scale analysis, we minimise the risks of therapy failure for the patient - saving money, reducin 'trail ...
Exacta is a comprehensive in-depth tumour gene expression analysis. It analyses 100’s of millions of data points at ...
  • The HRD test is designed to evaluate the status of homologous recombination repair in cancer cells.
  • It ...
NGS analysis covers:
  • DNA sequencing (523 genes)
  • RNA sequencing (55 genes)
  • CNV
  • Tumour mutational burden (TMB)
  • microsatellite ...
  • Comprehensive bone marrow and/or peripheral blood diagnostic evaluation
  • Includes a full clinical history review, morphology, flow cytometry, ...
  • Bone marrow and/or peripheral blood diagnostic profile
  • Utilising next-generation sequencing (NGS)
  • evaluate over 670 genes across various ...
NGS analysis covers:
  • DNA sequencing (523 genes)
  • RNA sequencing (55 genes)
  • CNV
  • Tumour mutational burden (TMB)
  • microsatellite ...
The Lumera Xpanded Solid Tumor Profile combines next-generation sequencing (N GS) with comprehensive molecular pathology case review and ...
  • A NMPA-approved NGS-based CDx kit solution detects genetic variations (SNV, InDel, CNV, and fusion) in EGFR, MET, ...
  • A 520-gene panel covers cancer-related genes targeted by commercialized and investigational drugs.
  • Enables detections of genetic alterations ...
  • A LDT blood test covering 168 clinically actionable cancer-related genes.
  • Detects alterations such as SNV, InDel,CNV and ...
  • A NGS-based CDx kit solution for NSCLC, CRC and GIST.
  • This 13-gene panel detects genetic variations (SNV, ...
  • A 520-gene panel covers cancer-related genes targeted by commercialized and investigational drugs.
  • Enables detections of genetic alterations ...